ELVN icon

Enliven Therapeutics

62 hedge funds and large institutions have $541M invested in Enliven Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 7 closing their positions.

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
0.91%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
8
Increased
23
Reduced
13
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
A
51
AJOVista
Massachusetts
$28.3K 2,046 +2,046 New
AB
52
Amalgamated Bank
New York
$28K 2,036 -234 -10%
Osaic Holdings
53
Osaic Holdings
Arizona
$27.7K 2,000
AIP
54
Ameritas Investment Partners
Nebraska
$26.7K 1,928
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
$17.7K 1,279
BWM
56
Baystate Wealth Management
Massachusetts
$692 50
GI
57
GAMMA Investing
California
$581 37 +37 New
Russell Investments Group
58
Russell Investments Group
United Kingdom
$166 12 +12 New
Nisa Investment Advisors
59
Nisa Investment Advisors
Missouri
$125 9
FFA
60
Farther Finance Advisors
California
$83 6 +6 New
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$69 5 +5 New
CAM
62
Cormorant Asset Management
Massachusetts
-1,216,712 Closed
FLSM
63
Frazier Life Sciences Management
California
-1,050,483 Closed
JC
64
JBF Capital
Colorado
-27,006 Closed
BCM
65
Bridgeway Capital Management
Texas
-17,950 Closed
AQR Capital Management
66
AQR Capital Management
Connecticut
-12,972 Closed
Allspring Global Investments
67
Allspring Global Investments
North Carolina
-566 Closed
UBS Group
68
UBS Group
Switzerland
-105 Closed
C
69
Covestor
United Kingdom
$0 1
Susquehanna International Group
70
Susquehanna International Group
Pennsylvania
CFGS
71
Concourse Financial Group Securities
Alabama